Therefore, we hypothesized that during hyperglycemia, CHIP activity is downregulated, and it is unable to perform its function, resulting in upregulation of p53 activity and leading to the loss of stemness of WJMSCs. The gene discussed is TP53; the disease is Hyperglycemia.